https://www.selleckchem.com/products/PLX-4032.html
5; 95% CI 1.4-1.6, .001) independent of race, insurance, receptor status, and stage. This study demonstrates significant associations with refusal of breast cancer treatment and quantifies the impact on mortality, which may help to identify at-risk groups for whom interventions could prevent increases in mortality associated with declining treatment. This study demonstrates significant associations with refusal of breast cancer treatment and quantifies the impact on mortality, which may help to identify at-risk groups for whom int
Like
Comment
Share
